Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reimbursement Briefs: CMS Looks Ahead On Competitive Bidding; Comment Requests

This article was originally published in The Gray Sheet

Executive Summary

CMS requests comments on competitive bidding program, extends deadline for information requested on two prospective models for paying specialty practitioners for services in the outpatient setting, and requests comments on quality measures for ESRD initiative. Ocular Therapeutix receives a Category III CPT code.

You may also be interested in...



DME Suppliers Down 27 Percent In Competitive Bidding Areas In 2012 – GAO

Durable medical equipment suppliers dropped by 27 percent in Medicare competitive bidding areas while only 5 percent of DME suppliers were lost in comparable, non-bidding areas. But the second year of the program’s round 1 rebid in 2012 saved Medicare $400 million, according to a newly-released Government Accountability Office report.

Reimbursement Briefs: AMA Wants ICD-10 Halt; News From CMS, AHRQ And OIG

AMA asks CMS to reconsider ICD-10 implementation. CMS explores specialist payment models. AHRQ quality measures clearinghouse endorses new Medicare hip and knee replacement measures tied to readmissions and complications. More reimbursement news.

Reimbursement In Brief

CMS opens national coverage analysis on VADs, proposes regulatory reform and announces new ESRD initiative. More reimbursement news.

Related Companies

UsernamePublicRestriction

Register

ID1132679

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel